Instituto de Diagnóstico y Referencia Epidemiológicos (InDRE) "Dr. Manuel Martínez Báez", Secretaría de Salud, Mexico City, Mexico.
Laboratorio de Investigación Clínica y Ambiental, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico City, Mexico.
Arch Virol. 2019 Dec;164(12):2953-2961. doi: 10.1007/s00705-019-04407-6. Epub 2019 Sep 24.
Human papillomavirus genotype 16 (HPV16) is the most frequent high-risk HPV (HR-HPV) identified in cervical precursor lesions and cervical cancer (CC) worldwide. The oncogenic potential of HPV16 is partly dependent on the lineage involved in the infection and the presence of clinically relevant mutations. In this report, we present the distribution of HR-HPV and the mutational profile and intra-host variability of HPV16 lineages, based on analysis of the long control region (LCR) and the E6 gene in samples with normal cytology (n = 39), squamous intraepithelial lesions (n = 25), and CC (n = 39). HR-HPV genotyping was performed using multiplex real-time PCR. HPV16 lineage assignments and mutation frequencies were determined by conventional PCR and Sanger DNA sequencing, and intra-patient viral populations were analyzed using next-generation sequencing (NGS). The most frequent HR-HPV type was HPV16, followed by HPV31 and HPV18. The frequency of HPV16 sublineages was A1/A2 > D2 > D3 and B1. Moreover, the most frequent mutations, both in samples from this study and in the available sequences from Mexican isolates in the GenBank database were LCR-G7518A, which is involved in carcinogenesis, and E6-T350G (producing L83V), associated with persistence of infection. Otherwise, deep sequencing revealed high conservation of viral lineages and mutations, independently of the stages studied. In conclusion, the high frequency and stability of these molecular markers, as well as the circulating viral lineages, could be related to the incidence of CC associated with HPV16. Hence, they deserve a broader analysis to determine the risk of specific populations for progression of the disease.
人乳头瘤病毒 16 型(HPV16)是全球宫颈前病变和宫颈癌(CC)中最常见的高危 HPV(HR-HPV)。HPV16 的致癌潜能部分取决于感染的谱系和存在临床相关的突变。在本报告中,我们根据正常细胞学(n = 39)、鳞状上皮内病变(n = 25)和 CC(n = 39)样本中长控制区(LCR)和 E6 基因的分析,报告了 HR-HPV 的分布以及 HPV16 谱系的突变谱和宿主内变异性。使用多重实时 PCR 进行 HR-HPV 基因分型。通过常规 PCR 和 Sanger DNA 测序确定 HPV16 谱系分配和突变频率,并使用下一代测序(NGS)分析患者内病毒群体。最常见的 HR-HPV 类型是 HPV16,其次是 HPV31 和 HPV18。HPV16 亚谱系的频率为 A1/A2 > D2 > D3 和 B1。此外,本研究样本中最常见的突变以及 GenBank 数据库中来自墨西哥分离株的可用序列中的最常见突变均为 LCR-G7518A,其参与致癌作用,而 E6-T350G(产生 L83V)与感染的持续性有关。否则,深度测序显示病毒谱系和突变高度保守,与研究的阶段无关。总之,这些分子标志物的高频率和稳定性以及循环病毒谱系可能与 HPV16 相关的 CC 发生率有关。因此,值得更广泛地分析以确定特定人群疾病进展的风险。